Publication Name	World Journal of Gastroenterology
Manuscript ID	97231
Country	Thailand

Received	2024-05-26 09:48
Peer-Review Started	2024-05-26 09:49
To Make the First Decision
Return for Revision	2024-08-10 06:22
Revised	2024-08-19 17:20
Second Decision	2024-08-27 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-08-27 06:15
Articles in Press	2024-08-27 06:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-03 07:51
Publish the Manuscript Online	2024-09-10 09:27

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemistry & Molecular Biology
Manuscript Type	Editorial
Article Title	Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma
Manuscript Source	Invited Manuscript
All Author List	Ronnakrit Trakoonsenathong, Ching-Feng Chiu and Charupong Saengboonmee
ORCID	Author(s) ORCID Number Ronnakrit Trakoonsenathong http://orcid.org/0009-0006-9235-8449 Ching-Feng Chiu http://orcid.org/0000-0001-5591-0288 Charupong Saengboonmee http://orcid.org/0000-0003-1476-1129
Funding Agency and Grant Number	Funding Agency Grant Number Mekong - Lancang Cooperation Special Fund Cho-Kalaphruek Excellent Research Project for Medical Students The International Internship Pilot Program IIPP2023283
Corresponding Author	Charupong Saengboonmee, MD, PhD, Assistant Professor, Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 123 Mittraphap Highway, Khon Kaen 40002, Thailand. charusa@kku.ac.th
Key Words	Carcinogenesis; Cholangiocarcinoma; Diabetes mellitus; Incretin; Glucagon-like peptide 1 receptor
Core Tip	Glucagon-like peptide 1 receptor (GLP-1R) agonists, an anti-diabetic drug with other systemic benefits, have been reported for their association with increased risk of some cancers. Although the associations between GLP-1R agonists and the risk of cholangiocarcinoma (CCA) have not been consensus, the use of GLP-1R agonists showed the anti-tumor effects against CCA in vitro and animal models are evident. This editorial reviews and discusses recent studies of the effects of GLP-1R agonists both at epidemiological and molecular levels. The understanding of how GLP-1R agonist affects CCA will be beneficial for the management of patients with CCA and diabetes mellitus.
Publish Date	2024-09-10 09:27
Citation	<p>Trakoonsenathong R, Chiu CF, Saengboonmee C. Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma. <i>World J Gastroenterol</i> 2024; 30(34): 3862-3867</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i34/3862.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i34.3862

Full Article (PDF)	WJG-30-3862-with-cover.pdf
Manuscript File	97231_Auto_Edited_025704.docx
Answering Reviewers	97231-answering-reviewers.pdf
Audio Core Tip	97231-audio.m4a
Conflict-of-Interest Disclosure Form	97231-conflict-of-interest-statement.pdf
Copyright License Agreement	97231-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	97231-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	97231-non-native-speakers.pdf
Peer-review Report	97231-peer-reviews.pdf
Scientific Misconduct Check	97231-scientific-misconduct-check.png
Scientific Editor Work List	97231-scientific-editor-work-list.pdf
CrossCheck Report	97231-crosscheck-report.pdf
CrossCheck Report	97231-crosscheck-report.png